Targeting BCL-2 and PI3K signaling pathways enhances cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cells. - Opydo M; Wojtaszek M; Mosurek A; Burczyk G; Such A; Kolaczkowska E (Biochemical and biophysical research communications, 2026)